Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Psychiatry/Psychology

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Memory Loss Clinical Trials

A listing of Memory Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (44) clinical trials

The MISSION-AD study is investigating the efficacy and safety of an investigational drug on symptoms of cognitive decline in individuals with mild cognitive impairment or early Alzheimer's disease. The study drug is a tablet which is taken by mouth once per day. The study will last approximately two years. Eligibility ...

Phase N/A

Have you noticed a decline in your memory or the memory of someone close to you? Meridien Research needs volunteers for a 24-month study of an investigational Alzheimer’s disease drug.

Phase N/A

For some people, dementia and Alzheimer’s disease (AD) can make them feel restless or upset. The ITI-007-201 Agitation Study is looking at an investigational medication to see if it is safe and works well to help reduce how often people with dementia, including AD feel upset or anxious. If you ...

Phase N/A

Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials.

Phase N/A

A 24-month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer’s Disease (The AMARANTH Study).

Phase N/A

Do you or someone you know have worsening memory or mild cognitive impairment? Then you may be interested in the EXPEDITION-PRO clinical research study. We're looking for volunteers to help us find out whether an investigational medication can slow the rate of cognitive and functional decline. To learn more please ...

Phase N/A

SPRI is currently participating in a multi-center, 24-month clinical evaluation of an investigational drug for people suffering from mild cognitive impairment (MCI) or mild Alzheimer’s disease (AD).

Phase N/A

Primary objective: to evaluate the efficacy of AZD3293 on cognitive and functional outcomes in patients with early Alzheimer’s disease (AD) as measured by the Clinical Dementia Rating - Sum of Boxes (CDR-SB) score. Early AD is defined as the continuum of patients with mild cognitive impairment (MCI) due to AD ...

Phase N/A

A Research Study is being conducted to evaluate an oral investigational medication that may help slow down the progression of what could be very early Alzheimer’s disease. Prodromal Alzheimer’s disease is the very early stage of the disease when minor symptoms first appear. A diagnosis can only be confirmed through ...

Phase N/A

A Research Study is being conducted to evaluate an oral investigational medication that may help slow down the progression of what could be very early Alzheimer’s disease. Prodromal Alzheimer’s disease is the very early stage of the disease when minor symptoms first appear. A diagnosis can only be confirmed through ...

Phase N/A